Cargando…

STAT3 activation: A key factor in tumor immunoescape

Cancer growth is controlled by cancer cells (cell intrinsic phenomenon), but also by the immune cells in the tumor microenvironment (cell extrinsic phenomenon). Thus cancer progression is mediated by the activation of transcription programs responsible for cancer cell proliferation, but also induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Rébé, Cédric, Végran, Frédérique, Berger, Hélène, Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670267/
https://www.ncbi.nlm.nih.gov/pubmed/24058791
http://dx.doi.org/10.4161/jkst.23010
_version_ 1782271833317310464
author Rébé, Cédric
Végran, Frédérique
Berger, Hélène
Ghiringhelli, François
author_facet Rébé, Cédric
Végran, Frédérique
Berger, Hélène
Ghiringhelli, François
author_sort Rébé, Cédric
collection PubMed
description Cancer growth is controlled by cancer cells (cell intrinsic phenomenon), but also by the immune cells in the tumor microenvironment (cell extrinsic phenomenon). Thus cancer progression is mediated by the activation of transcription programs responsible for cancer cell proliferation, but also induced proliferation/activation of immunosuppressive cells such as Th17, Treg or myeloid derived suppressor cells (MDSCs). One of the key transcription factors involved in these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on STAT3 activation in immune cells, and how it impacts on tumor progression.
format Online
Article
Text
id pubmed-3670267
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-36702672013-09-19 STAT3 activation: A key factor in tumor immunoescape Rébé, Cédric Végran, Frédérique Berger, Hélène Ghiringhelli, François JAKSTAT Review Cancer growth is controlled by cancer cells (cell intrinsic phenomenon), but also by the immune cells in the tumor microenvironment (cell extrinsic phenomenon). Thus cancer progression is mediated by the activation of transcription programs responsible for cancer cell proliferation, but also induced proliferation/activation of immunosuppressive cells such as Th17, Treg or myeloid derived suppressor cells (MDSCs). One of the key transcription factors involved in these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on STAT3 activation in immune cells, and how it impacts on tumor progression. Landes Bioscience 2013-01-01 2013-01-01 /pmc/articles/PMC3670267/ /pubmed/24058791 http://dx.doi.org/10.4161/jkst.23010 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Review
Rébé, Cédric
Végran, Frédérique
Berger, Hélène
Ghiringhelli, François
STAT3 activation: A key factor in tumor immunoescape
title STAT3 activation: A key factor in tumor immunoescape
title_full STAT3 activation: A key factor in tumor immunoescape
title_fullStr STAT3 activation: A key factor in tumor immunoescape
title_full_unstemmed STAT3 activation: A key factor in tumor immunoescape
title_short STAT3 activation: A key factor in tumor immunoescape
title_sort stat3 activation: a key factor in tumor immunoescape
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670267/
https://www.ncbi.nlm.nih.gov/pubmed/24058791
http://dx.doi.org/10.4161/jkst.23010
work_keys_str_mv AT rebecedric stat3activationakeyfactorintumorimmunoescape
AT vegranfrederique stat3activationakeyfactorintumorimmunoescape
AT bergerhelene stat3activationakeyfactorintumorimmunoescape
AT ghiringhellifrancois stat3activationakeyfactorintumorimmunoescape